Valuation Novo Nordisk A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 09:46:38 2026-02-18 EST			5-day change	1st Jan Change
308.85 ^DKK	-0.34%		+0.57%	-5.17%

04:15am	Lurpak-maker Arla sees lower dairy prices and boost from protein products	RE
04:14am	NOVO NORDISK : Barclays remains Neutral	ZD

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	1,674,992	2,118,803	3,112,331	2,772,285	1,445,242	1,377,772	-	-
Change	-	26.5%	46.89%	-10.93%	-47.87%	-4.67%	-	-
Enterprise Value (EV) ¹	1,684,152	2,121,013	3,109,107	2,848,764	1,549,238	1,477,700	1,467,335	1,452,235
Change	-	25.94%	46.59%	-8.37%	-45.62%	-4.62%	-0.7%	-1.03%
P/E ratio	35.4x	38.4x	37.5x	27.6x	14.1x	14.8x	14.1x	12.8x
PBR	24x	25.6x	29.4x	19.3x	-	6.35x	5.6x	4.88x
PEG	-	2.2x	0.7x	1.3x	7.98x	-1.66x	2.9x	1.3x
Capitalization / Revenue	11.9x	12x	13.4x	9.55x	4.68x	4.77x	4.52x	4.32x
EV / Revenue	12x	12x	13.4x	9.81x	5.01x	5.12x	4.82x	4.55x
EV / EBITDA	26x	25.8x	27.8x	19.3x	10.4x	10.7x	10.1x	9.54x
EV / EBIT	28.7x	28.4x	30.3x	22.2x	12.1x	12.5x	11.8x	11.2x
EV / FCF	57.4x	37x	45.5x	38.6x	26.3x	26.5x	18.7x	16.5x
FCF Yield	1.74%	2.7%	2.2%	2.59%	3.81%	3.77%	5.35%	6.07%
Dividend per Share ²	5.2	6.2	9.4	11.4	11.7	10.87	11.44	12.63
Rate of return	1.41%	1.32%	1.35%	1.83%	3.6%	3.51%	3.69%	4.08%
EPS ²	10.37	12.22	18.62	22.63	23.03	20.98	21.99	24.21
Distribution rate	50.1%	50.7%	50.5%	50.4%	50.8%	51.8%	52%	52.2%
Net sales ¹	140,800	176,954	232,261	290,403	309,064	288,849	304,677	319,235
EBITDA ¹	64,669	82,171	111,987	147,446	149,640	137,621	144,753	152,246
EBIT ¹	58,644	74,809	102,574	128,339	127,658	117,995	124,478	129,978
Net income ¹	47,757	55,525	83,683	100,988	102,434	93,320	97,020	102,932
Net Debt ¹	9,160	2,210	-3,224	76,479	103,996	99,928	89,563	74,463
Reference price ²	367.50	469.00	698.10	624.20	325.25	309.90	309.90	309.90
Nbr of stocks (in thousands)	4,557,801	4,517,704	4,458,288	4,441,340	4,443,479	4,445,860	-	-
Announcement Date	2/2/22	2/1/23	1/31/24	2/5/25	2/3/26	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NOVO NORDISK A/S	14.77x	5.12x	10.74x	3.51%	218B
ELI LILLY AND COMPANY	31.01x	11.75x	23.61x	0.64%	926B
JOHNSON & JOHNSON	24.77x	6.01x	16.36x	2.18%	586B
ABBVIE INC.	65.02x	7.68x	19.02x	2.81%	412B
ROCHE HOLDING AG	19.35x	4.81x	11.94x	2.72%	382B
ASTRAZENECA PLC	33.11x	5.93x	17.67x	1.55%	326B
NOVARTIS AG	21.99x	6.1x	15x	2.65%	317B
MERCK & CO., INC.	15.7x	5.03x	10.98x	2.66%	302B
AMGEN INC.	25.23x	6.36x	11.23x	2.69%	201B
GILEAD SCIENCES, INC.	22.77x	7.04x	12.87x	2.14%	193B
Average	27.37x	6.58x	14.94x	2.35%	386.18B
Weighted average by Cap.	29.15x	7.39x	16.76x	2.05%